TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34916635

Group type: EXPERIMENTAL
Intervention: Glass fibre posts with composite resin restorations
Number of subjects: 141

Group type: COMPARATOR
Intervention: Cast metal posts with metal-ceramic crowns
Number of subjects: 141

Group type: COMPARATOR
Intervention: Crown re-cementation
Number of subjects: 141

Group type: COMPARATOR
Intervention: Repair of resin restoration
Number of subjects: 141
Study: 33204865

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 50
Study: 32134291

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy adapted for patients with IBS (MBCT-IBS)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 67
Study: 35553053

Group type: EXPERIMENTAL
Intervention: Adjuvant immune checkpoint inhibition (aCPI)
Number of subjects: 1518

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1518

Group type: COMPARATOR
Intervention: Simulation of observation arm with informative censoring
Number of subjects: 1518
Study: 33334505

Group type: EXPERIMENTAL
Intervention: AKL-T01
Number of subjects: 348

Group type: COMPARATOR
Intervention: Control
Number of subjects: 348
Study: 33634592

Group type: EXPERIMENTAL
Intervention: Post-simulation hot debriefing (PSHD)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Cold debriefing (PSCD)
Number of subjects: 59
Study: 33030515

Group type: COMPARATOR
Intervention: Paclitaxel (80 mg/m2, days 1, 8, and 15 every 4 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Paclitaxel with Bevacizumab (10 mg/kg, every 2 weeks for 6 cycles, followed by maintenance bevacizumab 15 mg/kg every 3 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Paclitaxel with Bevacizumab
Number of subjects: 60
Study: 36173407

Group type: EXPERIMENTAL
Intervention: In-person proctoring (G2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Remote proctoring (G3)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No assistance (G1)
Number of subjects: 36
Study: 33754315

Group type: EXPERIMENTAL
Intervention: Somapacitan (0.08 mg/kg) in severe kidney impairment requiring hemodialysis
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Somapacitan (0.08 mg/kg) in moderate kidney impairment
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Somapacitan (0.08 mg/kg) in severe kidney impairment
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Somapacitan (0.08 mg/kg) in kidney impairment requiring hemodialysis
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Somapacitan (0.08 mg/kg) in moderate hepatic impairment
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Somapacitan (0.08 mg/kg) in mild hepatic impairment
Number of subjects: 78
Study: 36363502

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) program
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Motor Imagery Training (MIT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 34
Study: 34608713

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided (USG) arthrocentesis
Number of subjects: 44

Group type: COMPARATOR
Intervention: Landmark-guided (LMG) arthrocentesis
Number of subjects: 44
Study: 34427452

Group type: EXPERIMENTAL
Intervention: Entrectinib
Number of subjects: 94

Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 94
Study: 35894080

Group type: EXPERIMENTAL
Intervention: Liraglutide (3 mg subcutaneously daily)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 32715996

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 335

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 335
Study: 32286149

Group type: EXPERIMENTAL
Intervention: Opioid prescription
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: Assessment of pain
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: Country-specific opioid underuse rates
Number of subjects: 901
Study: 35339351

Group type: EXPERIMENTAL
Intervention: Anodal tDCS + Cognitive Stimulation (CS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham tDCS + Cognitive Stimulation (CS)
Number of subjects: 36
Study: 33247483

Group type: EXPERIMENTAL
Intervention: Citalopram (up to 40 mg/day) plus Tipepidine (30 mg twice daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Citalopram (up to 40 mg/day) plus Placebo
Number of subjects: 62
Study: 32061188

Group type: EXPERIMENTAL
Intervention: New drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 35407385

Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 38
Study: 32272022

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS) - budesonide
Number of subjects: 462

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: hsa-miR-155-5p and hsa-miR-532-5p
Number of subjects: 462
Study: 33186325

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg per day
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 34486579

Group type: EXPERIMENTAL
Intervention: Prediction equation group (116 eyes)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Verification group (58 eyes)
Number of subjects: 174
Study: 34181783

Group type: EXPERIMENTAL
Intervention: Self-control exertion (incongruent Stroop task)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (congruent Stroop task)
Number of subjects: 13
Study: 32725609

Group type: EXPERIMENTAL
Intervention: Video group (watching a video of a walking group)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Image group (watching a static image of flowers)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Video group
Number of subjects: 108

Group type: COMPARATOR
Intervention: Image group
Number of subjects: 108
Study: 36001916

Group type: COMPARATOR
Intervention: ABCD training
Number of subjects: 0

Group type: COMPARATOR
Intervention: UDS training
Number of subjects: 0

Group type: COMPARATOR
Intervention: All training types
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dermatological feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dermatological + Motivational feedback
Number of subjects: 0
Study: 33752439

Group type: EXPERIMENTAL
Intervention: Early rule-out pathway using high-sensitivity cardiac troponin I concentrations <5 ng/L at presentation.
Number of subjects: 31492
Study: 34347953

Group type: EXPERIMENTAL
Intervention: Decompression surgery (decompression-alone group)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Decompression surgery with instrumented fusion (fusion group)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Successful fusion
Number of subjects: 262
Study: 35865313

Group type: EXPERIMENTAL
Intervention: Intervention group (n=19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (n=19)
Number of subjects: 38
Study: 32960309

Group type: EXPERIMENTAL
Intervention: Nonoperative treatment of Lisfranc injuries
Number of subjects: 55
Study: 32815804

Group type: EXPERIMENTAL
Intervention: ISBPB with 20 cc of 0.25% levobupivacaine + 3.3 mg dexamethasone (group LD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: ISBPB with 20 cc of 0.25% levobupivacaine (group L)
Number of subjects: 54
Study: 36085169

Group type: EXPERIMENTAL
Intervention: BMI (< 23 kg/m2)
Number of subjects: 475813

Group type: EXPERIMENTAL
Intervention: BMI (> 30 kg/m2)
Number of subjects: 475813

Group type: EXPERIMENTAL
Intervention: High AD genetic risk score (AD-GRS) and BMI (< 23 kg/m2)
Number of subjects: 475813

Group type: COMPARATOR
Intervention: Higher BMI
Number of subjects: 475813
Study: 34747093

Group type: EXPERIMENTAL
Intervention: Group psychological counselling (n=38)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (n=41)
Number of subjects: 71
Study: 32683388

Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene (PTFE) strips as an adjunct to epinephrine impregnated gauze
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aluminum chloride (Expasyl™)
Number of subjects: 30
Study: 35147119

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34036728

Group type: EXPERIMENTAL
Intervention: Multimicronutrient‐fortified lipid‐based nutrient supplement containing 250‐μg I per day started immediately after randomization (Arm 1)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Multimicronutrient‐fortified lipid‐based nutrient supplement containing 250‐μg I per day started at 12 weeks gestation (Arm 2)
Number of subjects: 300

Group type: COMPARATOR
Intervention: No intervention supplement (Arm 3)
Number of subjects: 300
Study: 32081683

Group type: EXPERIMENTAL
Intervention: Skin traction (n = 18)
Number of subjects: 56

Group type: COMPARATOR
Intervention: No traction (n = 38)
Number of subjects: 56
Study: 34758350

Group type: EXPERIMENTAL
Intervention: Surgical excision
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Curettage
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Curettage or conservative wait-and-see approach
Number of subjects: 427
Study: 34900845

Group type: EXPERIMENTAL
Intervention: FreeStyle Libre 2 (second-generation isCGM) with education on using interstitial glucose data
Number of subjects: 100

Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: FreeStyle Libre 2 (second-generation isCGM)
Number of subjects: 100
Study: 35849009

Group type: EXPERIMENTAL
Intervention: High dose (3.5 g) of EPA + DHA
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low dose (2.0 g) of EPA + DHA
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 32
Study: 33809740

Group type: EXPERIMENTAL
Intervention: Video Feedback with Pedagogical Activity (VF‐PA)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Video Feedback (VF)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (CONT)
Number of subjects: 35
Study: 34254892

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy for perfectionism (ICBT-P)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (access to treatment 8 weeks post-randomisation)
Number of subjects: 89
Study: 33651735

Group type: EXPERIMENTAL
Intervention: Change of direction speed and technique modification training (2 sessions per week for 6 weeks)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Change of direction speed and technique modification training
Number of subjects: 27
Study: 33106863

Group type: EXPERIMENTAL
Intervention: Piperacillin/Tazobactam
Number of subjects: 379

Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 379
Study: 32408589

Group type: EXPERIMENTAL
Intervention: Medium cut-off membrane (Theranova)
Number of subjects: 5

Group type: COMPARATOR
Intervention: High-flux membrane (Revaclear)
Number of subjects: 5
Study: 35266378

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided serratus plane block (SPB) with 30 mL 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group received 2 mL saline injection subcutaneously
Number of subjects: 60
Study: 33084881

Group type: EXPERIMENTAL
Intervention: Robotic ventral hernia repair
Number of subjects: 75

Group type: COMPARATOR
Intervention: Laparoscopic ventral hernia repair
Number of subjects: 75
Study: 34089046

Group type: EXPERIMENTAL
Intervention: 4-fold increase in the Earned Income Tax Credit
Number of subjects: 5968
Study: 34932077

Group type: EXPERIMENTAL
Intervention: Proactive therapeutic drug monitoring (TDM) with dose and interval adjustments based on scheduled monitoring of serum drug levels and antidrug antibodies (n=228)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Standard infliximab therapy without drug and antibody level monitoring (n=230)
Number of subjects: 458
Study: 36173595

Group type: EXPERIMENTAL
Intervention: Broad-spectrum SPF 50 sunscreen (investigational product)
Number of subjects: 65

Group type: COMPARATOR
Intervention: SPF 50+ (P8) reference product
Number of subjects: 65

Group type: COMPARATOR
Intervention: SPF 30 (P5) reference product
Number of subjects: 65

Group type: COMPARATOR
Intervention: SPF 15 (P3) reference product
Number of subjects: 65

Group type: COMPARATOR
Intervention: Unprotected positive control area
Number of subjects: 65

Group type: COMPARATOR
Intervention: Non-exposed negative control area
Number of subjects: 65
Study: 32876654

Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography and PCI if indicated
Number of subjects: 552

Group type: COMPARATOR
Intervention: Delayed coronary angiography and PCI if indicated
Number of subjects: 552
Study: 35121062

Group type: EXPERIMENTAL
Intervention: Yerba mate infusion (300 mL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hot tea (300 mL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cold tea (300 mL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison of hot tea and yerba mate infusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 30

Group type: COMPARATOR
Intervention: All subjects
Number of subjects: 30
Study: 32813407

Group type: EXPERIMENTAL
Intervention: Early palliative care interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 32408846

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) for 8 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (single session of needs assessment, brief counseling/education, and referral)
Number of subjects: 93
Study: 33427183

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Foster care
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Never-institutionalized
Number of subjects: 3
Study: 36502333

Group type: EXPERIMENTAL
Intervention: M. officinalis extract (500 mg of RA per day)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: M. officinalis extract
Number of subjects: 323
Study: 34161564

Group type: EXPERIMENTAL
Intervention: Pain training
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 158
Study: 35687394

Group type: EXPERIMENTAL
Intervention: OutsidePlay‐ECE risk‐reframing intervention
Number of subjects: 563

Group type: COMPARATOR
Intervention: Position Statement on Active Outdoor Play (Control)
Number of subjects: 563
Study: 34478124

Group type: EXPERIMENTAL
Intervention: Repository corticotropin injection (RCI; Acthar® Gel) 80 U subcutaneously every other day for 4 weeks and then twice weekly through week 24
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repository corticotropin injection (RCI; Acthar® Gel)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36141903

Group type: EXPERIMENTAL
Intervention: Flower arrangement with stocks and carnations
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flower arrangement with lilies
Number of subjects: 30
Study: 32559052

Group type: EXPERIMENTAL
Intervention: Cementless tibial fixation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cemented tibial fixation
Number of subjects: 100
Study: 36369781

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided genicular nerve block (GNB) with 5.7 mg celestone chronodose (1 ml) and 0.5% bupivacaine (3 ml)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided genicular nerve block (GNB)
Number of subjects: 59
Study: 33517291

Group type: EXPERIMENTAL
Intervention: TissuGlu®
Number of subjects: 70

Group type: COMPARATOR
Intervention: Drain
Number of subjects: 70
Study: 35345271

Group type: EXPERIMENTAL
Intervention: Endovascular therapeutic hypothermia (ETH) for 18 minutes at a target temperature of 32 ± 1.0 ◦C
Number of subjects: 50

Group type: COMPARATOR
Intervention: PCI-only (control group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison of door-to-balloon time between ETH and control
Number of subjects: 50
Study: 33952684

Group type: EXPERIMENTAL
Intervention: Obturator nerve block with 20 mL of ropivacaine 0.2%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham block (placebo group) with saline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Obturator nerve block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham block (placebo group)
Number of subjects: 60
Study: 32701129

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus radiotherapy (IMRT after chemotherapy)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 126
Study: 34724405

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) intervention teaching pain self‐management skills in 12 weekly, 90‐minute groups delivered by an interdisciplinary team.
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) intervention
Number of subjects: 850

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 850
Study: 34553395

Group type: EXPERIMENTAL
Intervention: GSH-FBT (online guided self-help family-based treatment) for parents, 12 sessions of 20 minutes each
Number of subjects: 40

Group type: COMPARATOR
Intervention: FBT-V (family-based treatment delivered via videoconferencing), 15 sessions of 60 minutes each
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: GSH-FBT
Number of subjects: 40

Group type: COMPARATOR
Intervention: FBT-V
Number of subjects: 40
Study: 33067703

Group type: EXPERIMENTAL
Intervention: Carboplatin (AUC5) and bevacizumab (10 mg/kg) every 3 weeks
Number of subjects: 73
Study: 34774015

Group type: EXPERIMENTAL
Intervention: ASICA intervention
Number of subjects: 121
Study: 33198867

Group type: EXPERIMENTAL
Intervention: ΔP guided sedation strategy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Light sedation strategy
Number of subjects: 60
Study: 34378159

Group type: EXPERIMENTAL
Intervention: Remote ischemic postconditioning (RIPostC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 33941150

Group type: EXPERIMENTAL
Intervention: Cervical-lesion group (106 patients)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Non-cervical-lesion group (79 patients)
Number of subjects: 185
Study: 35522237

Group type: EXPERIMENTAL
Intervention: Optional Results Choice Aid (ORCA)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Web-based additional findings information
Number of subjects: 231
Study: 33063541

Group type: EXPERIMENTAL
Intervention: Vegan multi-ingredient (VGMT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Maltodextrin (MALT)
Number of subjects: 10
Study: 35610297

Group type: EXPERIMENTAL
Intervention: Commercial activity tracker bracelet with daily activity goal and inactivity alerts for 12 months
Number of subjects: 231

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 231
Study: 616774613

Group type: EXPERIMENTAL
Intervention: Endoscopic concurrent therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sequential therapy (Control)
Number of subjects: 60
Study: 35860947

Group type: EXPERIMENTAL
Intervention: Mindful eating intervention
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Mindful eating + planning intervention
Number of subjects: 55
Study: 35274723

Group type: EXPERIMENTAL
Intervention: Enfortumab vedotin
Number of subjects: 0
Study: 32463470

Group type: EXPERIMENTAL
Intervention: Bupropion (150 mg for 4 weeks plus 300 mg for 8 weeks)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 108
Study: 36280809

Group type: EXPERIMENTAL
Intervention: ECD program (parenting training sessions and home-based training)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ECD program with monthly developmental feedback
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18
Study: 34147335

Group type: EXPERIMENTAL
Intervention: K‐K9 group (acupressure with Black Pepper Seed)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: P6 group (acupressure with wristband)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 103
Study: 34600346

Group type: EXPERIMENTAL
Intervention: Day 2 frozen embryo transfer (group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Overnight day 3 frozen embryo transfer (group B)
Number of subjects: 72
Study: 34415794

Group type: COMPARATOR
Intervention: Tasking conditions (verbal, tactile) during rotary chair testing
Number of subjects: 20

Group type: COMPARATOR
Intervention: No tasking condition
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Different types of tasking (verbal, tactile)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mental or tactile tasking
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Braiding tactile task
Number of subjects: 20

Group type: COMPARATOR
Intervention: Caloric testing
Number of subjects: 20
Study: 33109254

Group type: EXPERIMENTAL
Intervention: Telehealth technology plus centralised remote support
Number of subjects: 51

Group type: COMPARATOR
Intervention: Telehealth technology alone
Number of subjects: 51
Study: 36104012

Group type: EXPERIMENTAL
Intervention: Domagrozumab
Number of subjects: 0
Study: 33169672

Group type: EXPERIMENTAL
Intervention: Tezepelumab (70 mg every 4 weeks, 210 mg every 4 weeks, or 280 mg every 2 weeks)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Tezepelumab
Number of subjects: 550
Study: 32103903

Group type: EXPERIMENTAL
Intervention: Cefotetan disodium 0.5 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefotetan disodium 1.0 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefotetan disodium 2.0 g
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefotetan disodium 1.0 g BID for 7 days
Number of subjects: 0
Study: 32915004

Group type: EXPERIMENTAL
Intervention: Gratitude intervention (10 min of gratitude writing per week for 4 weeks)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control (listing daily activities and reflecting on obstacles and benefits)
Number of subjects: 1000
Study: 35381421

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion at 25 µg/min
Number of subjects: 150

Group type: COMPARATOR
Intervention: Normal saline infusion (Control)
Number of subjects: 150
Study: 35129606

Group type: EXPERIMENTAL
Intervention: KeySteps@JC Parent‐Child Interaction program
Number of subjects: 267